Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction

Statins lower low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hsCRP), and the addition of ezetimibe to statins further reduces LDL-C and hsCRP. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a potentially important pathogenic factor participating in the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yizhi, Zhu, Hao, Fan, Zhongguo, Gao, Yali, Tian, Nailiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704334/
https://www.ncbi.nlm.nih.gov/pubmed/29201198
http://dx.doi.org/10.3892/etm.2017.5175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704334/
https://www.ncbi.nlm.nih.gov/pubmed/29201198
http://dx.doi.org/10.3892/etm.2017.5175

Ejemplares similares